These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 3264755)
61. Riluzole and experimental parkinsonism: antagonism of MPTP-induced decrease in central dopamine levels in mice. Boireau A; Dubédat P; Bordier F; Peny C; Miquet JM; Durand G; Meunier M; Doble A Neuroreport; 1994 Dec; 5(18):2657-60. PubMed ID: 7696626 [TBL] [Abstract][Full Text] [Related]
62. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Sirinathsinghji DJ; Whittington PE; Audsley AR Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361 [TBL] [Abstract][Full Text] [Related]
63. Comparison of brain dopamine depletion induced by low-dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in young and aged rats. Tsai YF; Tsai HW; Tai MY Neurosci Res; 1994 Jul; 20(1):27-33. PubMed ID: 7984338 [TBL] [Abstract][Full Text] [Related]
64. Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice. Ookubo M; Yokoyama H; Takagi S; Kato H; Araki T Mol Cell Endocrinol; 2008 Dec; 296(1-2):87-93. PubMed ID: 18755240 [TBL] [Abstract][Full Text] [Related]
65. Morphological, neurochemical, and behavioral characterizations associated with the combined treatment of diethyldithiocarbamate and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Yurek DM; Deutch AY; Roth RH; Sladek JR Brain Res; 1989 Sep; 497(2):250-9. PubMed ID: 2573405 [TBL] [Abstract][Full Text] [Related]
67. Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment. Fillebeen C; Mitchell V; Dexter D; Benaissa M; Beauvillain J; Spik G; Pierce A Brain Res Mol Brain Res; 1999 Oct; 72(2):183-94. PubMed ID: 10529477 [TBL] [Abstract][Full Text] [Related]
68. Gender differences on MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in C57BL/6 mice. Ookubo M; Yokoyama H; Kato H; Araki T Mol Cell Endocrinol; 2009 Nov; 311(1-2):62-8. PubMed ID: 19631714 [TBL] [Abstract][Full Text] [Related]
69. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on retinal dopaminergic system in mice. Hamilton WR; Trickler WJ; Robinson BL; Paule MG; Ali SF Neurosci Lett; 2012 May; 515(2):107-10. PubMed ID: 22414866 [TBL] [Abstract][Full Text] [Related]
70. Chronic L-deprenyl does not alter the restoration of striatal dopamine in MPTP-lesioned mice. Wiener HL; Hashim A; Lajtha A; Sershen H J Neurosci Res; 1989 Jul; 23(3):326-9. PubMed ID: 2504936 [TBL] [Abstract][Full Text] [Related]
71. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the mouse: relationships between monoamine oxidase, MPTP metabolism and neurotoxicity. Heikkila RE; Hess A; Duvoisin RC Life Sci; 1985 Jan; 36(3):231-6. PubMed ID: 3917525 [TBL] [Abstract][Full Text] [Related]
72. Striatal and urinary DOPAC/DA ratio may indicate a long-lasting DA release enhancement by MPP+ and MPTP. Bagchi SP Neurochem Res; 1998 Feb; 23(2):127-34. PubMed ID: 9475505 [TBL] [Abstract][Full Text] [Related]
73. Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility. Hofele K; Sedelis M; Auburger GW; Morgan S; Huston JP; Schwarting RK Exp Neurol; 2001 Mar; 168(1):116-22. PubMed ID: 11170726 [TBL] [Abstract][Full Text] [Related]
74. Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sources. Heikkila RE Eur J Pharmacol; 1985 Oct; 117(1):131-3. PubMed ID: 3878793 [TBL] [Abstract][Full Text] [Related]
75. Age-related susceptibility to MPTP-induced neurotoxicity in mice. Ali SF; David SN; Newport GD Neurotoxicology; 1993; 14(1):29-34. PubMed ID: 8361676 [TBL] [Abstract][Full Text] [Related]
76. 4-Phenylpyridine (4PP) and MPTP: the relationship between striatal MPP+ concentrations and neurotoxicity. Irwin I; Langston JW; DeLanney LE Life Sci; 1987 Feb; 40(8):731-40. PubMed ID: 3492652 [TBL] [Abstract][Full Text] [Related]
77. Zonisamide increases dopamine turnover in the striatum of mice and common marmosets treated with MPTP. Yabe H; Choudhury ME; Kubo M; Nishikawa N; Nagai M; Nomoto M J Pharmacol Sci; 2009 May; 110(1):64-8. PubMed ID: 19403994 [TBL] [Abstract][Full Text] [Related]
78. Effect of serotonergic, corticostriatal and kainic acid lesions on the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in mice. Melamed E; Pikarski E; Goldberg A; Rosenthal J; Uzzan A; Conforti N Brain Res; 1986 Dec; 399(1):178-80. PubMed ID: 3492237 [TBL] [Abstract][Full Text] [Related]
79. Pharmacological effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine receptor system. Lau YS; Fung YK Brain Res; 1986 Mar; 369(1-2):311-5. PubMed ID: 3486026 [TBL] [Abstract][Full Text] [Related]
80. Intrastriatal injection of 5,7-dihydroxytryptamine decreased 5-HT levels in the striatum and suppressed locomotor activity in C57BL/6 mice. Chia LG; Ni DR; Cheng FC; Ho YP; Kuo JS Neurochem Res; 1999 Jun; 24(6):719-22. PubMed ID: 10447454 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]